DXR - Daxor Operating profit before deduction of amortization

Brandmark of daxor.com (DXR)

The risk of stagnating equipment demand is offset by stable cash flow, as confirmed by the EBITDA trend on the GURU.Markets chart, where the 6.26 level indicates the parameter's status. Daxor Corporation (DXR) ensures business resilience through partnerships with cardiology centers treating heart failure and the implementation of the BVA-100 system, which creates high hospital dependency on proprietary software.

DXR - Daxor Corporation Profit before payment of interest, taxes and amortization over the range 11/23/2025 - 11/12/2026

Daxor (DXR) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Market Chart Daxor Corp|DXR - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Daxor|DXR - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value of a Share Daxor|DXR - Company Book Value|Market Cap to Net Assets Ratio daxor.com|DXR - Company Total Assets
- company total debt and liquidity indicators:
Debt to Capital Daxor Corporation|DXR - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Daxor Corp|DXR - Company Aggregate Debts|Debts to Net Assets Daxor|DXR - Company Long-Term Debts|Company Current Liabilities Daxor|Quick Ratio daxor.com
- earnings and market ratios statistics:
DXR - Company Net Income|Expected Profit Daxor Corporation|DXR - Price to Earnings Ratio|Future Price to Earnings Multiple Daxor Corp|DXR - PEG Multiple|Company Value to EBITDA Daxor|DXR - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year Daxor|DXR - Net earnings per share for the last 12 months|Quarterly EPS earnings growth daxor.com|DXR - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Daxor Corporation
Summary company analytics:DXR Daxor Corporation
Manufactured product of Daxor Corporation

To protect capital amid volatility, it is critical for investors to track real cash flow from sales without the influence of debt burdens and taxes. An analysis of EBITDA allows for the identification of hidden efficiency trends for the BVA-100, confirming that unique blood volume diagnostics translate into sustainable operational growth and capitalization for Daxor Corporation (DXR).

Who Daxor Corporation competes with

Operating income before deduction of amortization Abbott Corp. (ABT)|Thermo Fisher Scientific - Operating profit EBITDA|gehealthcare.com (GEHC) - Operating profit before deduction of amortization|MTD (Mettler Toledo) - Operating profit before deduction of amortization|Waters Corp - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Techne Corporation|Operating profit before deduction of amortization Bruker BioSpin (BRKR)|Operating profit EBITDA AZTA|VREX - Profit before interest, taxes and amortization|Operating profit EBITDA SMLR (Semler Scientific)|BFLY: Operating profit before amortization|Mesa Labs Corp - Operating profit EBITDA|Operating income before deduction of amortization Quantum-Si Corporation QSI|NNOX: Operating profit EBITDA|Operating profit before deduction of amortization quanterix.com|MASS (908 Devices) - Operating profit EBITDA|Operating profit EBITDA CapsoVision Medical|Profit before payment of interest, taxes and amortization MaxCyte, Inc (MXCT)|Profit before payment of interest, taxes and amortization RPID (rapidmicrobio.com)|Seer, Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HYPR|FONAR - Operating profit EBITDA|Profit before interest, taxes and amortization spectral-ai.com|Organovo Holdings, Inc. (VIVS) - Profit before payment of interest, taxes and amortization|Operating profit before depreciation charges Aclarion Corporation ACON|Operating profit before deduction of amortization AKYA|Operating profit EBITDA thermogenesis.com|Operating profit EBITDA TLIS|Operating income before deduction of amortization T2 Biosystems Inc.